Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I-Chih Chen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
ACS Applied Materials & Interfaces|February 24, 2017
Impacts of Cross-Linkers on Biological Effects of Mesoporous Silica NanoparticlesYi-Ping Chen, Si-Han Wu, I-Chih Chen, et al.
Journal of the Chinese Medical Association : JCMA|March 1, 2017
ReplyI-Chih Chen, Cheng-Han Lee, Yi-Heng Li, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 9, 2010
Rosiglitazone reduces plasma levels of inflammatory and hemostatic biomarkers and improves global endothelial function in habitual heavy smokers without diabetes mellitus or metabolic syndromeI-Chih Chen, Ting-Hsing Chao, Wei-Chuan Tsai, et al.
Acta Cardiologica Sinica|April 29, 2016
Pluripotent Stem Cell Therapy in Ischemic Cardiovascular DiseaseTing-Hsing Chao, I-Chih Chen, Shi-Ya Tseng, et al.
Acta Cardiologica Sinica|October 8, 2016
Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal AngioplastyI-Chih Chen, Chao-Chin Yu, Yi-Hsuan Wu, et al.
Journal of the American Heart Association|May 22, 2016
Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor CellsTing-Hsing Chao, I-Chih Chen, Yi-Heng Li, et al.
Acta Cardiologica Sinica|September 29, 2021
Long-Term Clinical Outcomes of New-Generation Drug-Eluting Stents in Coronary Artery Disease: A Real-World Observational StudyHsun-Hao Chang, Chi-Feng Hung, I-Chih Chen, et al.
Oncotarget|January 4, 2018
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9I-Chih Chen, Wei-Kung Tseng, Yi-Heng Li, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|April 29, 2022
Erratum to "Midterm Mortality between Single or Multiple Exposure to Paclitaxel Coated Devices for the Treatment of Femoropopliteal Artery Disease [Eur J Vasc Endovasc Surg (2022) 63, 521-522]"Kuan-Liang Liu, I-Shiang Tzeng, I-Chih Chen, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 27, 2021
Midterm Mortality between Single or Multiple Exposure to Paclitaxel Coated Devices for the Treatment of Femoropopliteal Artery DiseaseKuan-Liang Liu, I-Shiang Tzeng, I-Chih Chen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
ACS Applied Materials & Interfaces|February 24, 2017
Impacts of Cross-Linkers on Biological Effects of Mesoporous Silica NanoparticlesYi-Ping Chen, Si-Han Wu, I-Chih Chen, et al.
Journal of the Chinese Medical Association : JCMA|March 1, 2017
ReplyI-Chih Chen, Cheng-Han Lee, Yi-Heng Li, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 9, 2010
Rosiglitazone reduces plasma levels of inflammatory and hemostatic biomarkers and improves global endothelial function in habitual heavy smokers without diabetes mellitus or metabolic syndromeI-Chih Chen, Ting-Hsing Chao, Wei-Chuan Tsai, et al.
Acta Cardiologica Sinica|April 29, 2016
Pluripotent Stem Cell Therapy in Ischemic Cardiovascular DiseaseTing-Hsing Chao, I-Chih Chen, Shi-Ya Tseng, et al.
Acta Cardiologica Sinica|October 8, 2016
Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal AngioplastyI-Chih Chen, Chao-Chin Yu, Yi-Hsuan Wu, et al.
Journal of the American Heart Association|May 22, 2016
Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor CellsTing-Hsing Chao, I-Chih Chen, Yi-Heng Li, et al.
Acta Cardiologica Sinica|September 29, 2021
Long-Term Clinical Outcomes of New-Generation Drug-Eluting Stents in Coronary Artery Disease: A Real-World Observational StudyHsun-Hao Chang, Chi-Feng Hung, I-Chih Chen, et al.
Oncotarget|January 4, 2018
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9I-Chih Chen, Wei-Kung Tseng, Yi-Heng Li, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|April 29, 2022
Erratum to "Midterm Mortality between Single or Multiple Exposure to Paclitaxel Coated Devices for the Treatment of Femoropopliteal Artery Disease [Eur J Vasc Endovasc Surg (2022) 63, 521-522]"Kuan-Liang Liu, I-Shiang Tzeng, I-Chih Chen, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 27, 2021
Midterm Mortality between Single or Multiple Exposure to Paclitaxel Coated Devices for the Treatment of Femoropopliteal Artery DiseaseKuan-Liang Liu, I-Shiang Tzeng, I-Chih Chen, et al.
Pageof 3